Skip to main content
Premium Trial:

Request an Annual Quote

Genesis Healthcare GenesisGaia

Japanese genetic research and testing firm Genesis Healthcare has introduced GenesisGaia, a generative artificial intelligence software platform that uses genomic datasets to reduce pharmaceutical R&D bottlenecks. Working with analytics company Xebral, Genesis has collected more than 31 million data points from public-sector and open-source datasets on genetics, variants, proteins, drug compounds, scientific publications, and clinical trials, and combined that information with its own collection of more than 400,000 genomes to create GenesisGaia.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.